189 related articles for article (PubMed ID: 35701808)
1. Prevalence of potential drug - drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital.
Wang H; Shi H; Wang N; Wang Y; Zhang L; Zhao Y; Xie J
BMC Pharmacol Toxicol; 2022 Jun; 23(1):39. PubMed ID: 35701808
[TBL] [Abstract][Full Text] [Related]
2. Drug-drug interactions in Neonatal Intensive Care Units: how to overcome a challenge.
Rosen K; Wiesen MH; Oberthür A; Michels G; Roth B; Fietz C; Müller C
Minerva Pediatr (Torino); 2021 Apr; 73(2):188-197. PubMed ID: 31621271
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
4. Drug-drug interactions in neonatal intensive care: A prospective cohort study.
Costa HT; Leopoldino RWD; da Costa TX; Oliveira AG; Martins RR
Pediatr Neonatol; 2021 Mar; 62(2):151-157. PubMed ID: 33158761
[TBL] [Abstract][Full Text] [Related]
5. Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved.
Smithburger PL; Kane-Gill SL; Seybert AL
Int J Pharm Pract; 2012 Dec; 20(6):402-8. PubMed ID: 23134100
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.
Khan Q; Ismail M; Haider I; Khan F
Int J Clin Pharm; 2017 Dec; 39(6):1256-1264. PubMed ID: 28895028
[TBL] [Abstract][Full Text] [Related]
7. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
Moura C; Prado N; Acurcio F
Clin Drug Investig; 2011; 31(5):309-16. PubMed ID: 21344954
[TBL] [Abstract][Full Text] [Related]
8. Potentially Hazardous Drug-Drug Interactions Associated With Oral Antineoplastic Agents Prescribed in Chinese Tertiary Care Teaching Hospital Settings: A Multicenter Cross-Sectional Study.
Wang H; Shi H; Wang Y; Wang N; Li Y; Yang Q; Li Y; Liu C; Zan Y; Feng S; Xie J
Front Pharmacol; 2022; 13():808848. PubMed ID: 35177990
[No Abstract] [Full Text] [Related]
9. Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.
Benoist GE; van Oort IM; Smeenk S; Javad A; Somford DM; Burger DM; Mehra N; van Erp NP
Br J Clin Pharmacol; 2018 Jan; 84(1):122-129. PubMed ID: 28881501
[TBL] [Abstract][Full Text] [Related]
10. [Drug-drug interactions in intensive care patients].
Saaby L; Olesen C; Fedder J; Haunstrup E
Ugeskr Laeger; 2009 Sep; 171(39):2817-22. PubMed ID: 19811752
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for potential drug-drug interactions in intensive care unit patients.
Janković SM; Pejčić AV; Milosavljević MN; Opančina VD; Pešić NV; Nedeljković TT; Babić GM
J Crit Care; 2018 Feb; 43():1-6. PubMed ID: 28822348
[TBL] [Abstract][Full Text] [Related]
12. Incidence of potential drug interactions in a transplant centre setting and relevance of electronic alerts for clinical practice support.
Polidori P; Di Giorgio C; Provenzani A
Inform Prim Care; 2012; 20(4):257-62. PubMed ID: 23890337
[TBL] [Abstract][Full Text] [Related]
13. Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
Fettah H; Moutaouakkil Y; Sefrioui MR; Moukafih B; Bousliman Y; Bennana A; Lamsaouri J; Makram S; Cherrah Y
Pan Afr Med J; 2018; 29():225. PubMed ID: 30100979
[TBL] [Abstract][Full Text] [Related]
14. Potential drug-drug interactions in cardiothoracic intensive care unit of a pulmonary teaching hospital.
Farzanegan B; Alehashem M; Bastani M; Baniasadi S
J Clin Pharmacol; 2015 Feb; 55(2):132-6. PubMed ID: 25369984
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
Gonzaga de Andrade Santos TN; Mendonça da Cruz Macieira G; Cardoso Sodré Alves BM; Onozato T; Cunha Cardoso G; Ferreira Nascimento MT; Saquete Martins-Filho PR; Pereira de Lyra D; Oliveira Filho AD
PLoS One; 2020; 15(7):e0235353. PubMed ID: 32609783
[TBL] [Abstract][Full Text] [Related]
16. Potential drug-drug interactions among hospitalized patients in a developing country.
Mousavi S; Ghanbari G
Caspian J Intern Med; 2017; 8(4):282-288. PubMed ID: 29201319
[TBL] [Abstract][Full Text] [Related]
17. Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil.
Teixeira JJ; Crozatti MT; dos Santos CA; Romano-Lieber NS
PLoS One; 2012; 7(10):e47062. PubMed ID: 23071711
[TBL] [Abstract][Full Text] [Related]
18. Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.
Khan Q; Ismail M; Khan S
BMC Pharmacol Toxicol; 2017 Dec; 18(1):75. PubMed ID: 29191244
[TBL] [Abstract][Full Text] [Related]
19. Risk of potential drug-drug interactions in the cardiac intensive care units. A comparative analysis between 2 tertiary care hospitals.
Shakeel F; Khan JA; Aamir M; Hannan PA; Zehra S; Ullah I
Saudi Med J; 2018 Dec; 39(12):1207-1212. PubMed ID: 30520502
[TBL] [Abstract][Full Text] [Related]
20. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
